NVCN Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 bal. 2023 @ 23:00):

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally...

Stats
Dzisiejszy wolumen	1.00
Średni wolumen	25 784.00
Kapitalizacja rynkowa	82.86M
EPS	$0 ( 2024-03-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.993
ATR14	$0.436 (1.45%)

Wolumen Korelacja

Długi: 0.10 (neutral)

Krótki: 0.00 (neutral)

Signal:(63.994) Neutral

Neovasc Inc Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Neovasc Inc Korelacja - Waluta/Towar

0.72
( moderate )

0.62
( weak )

-0.76
( moderate negative )

0.76
( moderate )

0.24
( neutral )

-0.44
( neutral )

Neovasc Inc Finanse

Annual	2022
Przychody:	$3.81M
Zysk brutto:	$3.03M (79.66 %)
EPS:	$-15.07

FY	2022
Przychody:	$3.81M
Zysk brutto:	$3.03M (79.66 %)
EPS:	$-15.07

FY	2021
Przychody:	$2.55M
Zysk brutto:	$1.99M (78.19 %)
EPS:	$-10.00

FY	2020
Przychody:	$1.96M
Zysk brutto:	$1.51M (77.20 %)
EPS:	$-43.00

Financial Reports:

No articles found.

Neovasc Inc

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.